Focus on Cancer

Focus on Cancer

by

According to the American Cancer Society, yearly deaths from cancer are decreasing— marking the first period of decline in nearly 70 years. ReachMD takes a closer look at the driving forces behind these advances: medications that hone in on specific tumor targets, more accurate screening and diagnostic technologies, and pioneering surgical methods that provide new hope for patients suffering from these devastating diseases.

Recent Episodes

  • Higher Risk, Lowered Age: New Colorectal Cancer Screening Guidelines

    6 years ago
  • FDA D.I.S.C.O.: First Biosimilar Approval for the Treatment of Cancer

    6 years ago
  • CAR-T Cell Therapy: A Breakthrough Treatment for Fighting Cancer

    7 years ago
  • Pancreatic Cancer: The Hunt to Catch a Silent Killer

    7 years ago
  • FDA D.I.S.C.O.: Osimertinib for Non-Small Cell Lung Cancer

    7 years ago
  • FDA D.I.S.C.O.: Two Approvals for ALK-Positive Non-Small Cell Lung Cancer

    7 years ago
  • The CAM Guide to Cancer: An Integrative Approach to Prevention, Treatment, and Healing

    7 years ago
  • Linking p53 Variation to Breast Cancer Risk in African American Women

    7 years ago
  • FDA D.I.S.C.O.: First Tissue/Site Agnostic Cancer Treatment Approval

    7 years ago
  • The Financial Burden of Cancer: Report from the American Cancer Society

    7 years ago